Melexis NV (MELE) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Melexis NV stock €58.74, price €53.40, upside +10.0%, quality 60 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range €39.43 – €86.89 · fair‑value band €30.84 – €82.49 · the €53.40 price screens below the €58.74 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 8, 2026.
Follow Melexis in your weekly email
Every Wednesday you see whether Melexis is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle East, Africa, the Asia Pacific, and North and Latin America.
Show moreShow less
The company provides current, inductive position, latch and switch, magnetic position, speed, optical, pressure, temperature motor, and tire monitoring sensors ICs, as well as time-of-flight ICs; embedded motor, fan and pump, smart LED, pre-driver, and transceivers ICs, such as LIN, CAN, and RFID transceivers; and embedded lighting ICs. Melexis NV was founded in 1988 and is headquartered in Ieper, Belgium.
Stock analysis
Melexis NV (MELE) currently trades at €53.40, while our model-based Fair Value estimate is €58.74, so the stock looks roughly fairly valued today (gap 9.1%).
Show more
Valuation
Bull case: the Multiples group reads highest at a median of €74.00 per share, and 10 of the 26 models we run sit above the €53.40 price.
Bear case: the Economic Profit group reads lowest at €19.37, and 16 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: €30.84 (bear) to €82.49 (bull), the price of €53.40 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Technology sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Melexis NV reported revenue of €840M in FY2025 versus €644M in FY2021, a compound +6.9%/yr. Reported net income was €113M in FY2025, compounding −3.8%/yr from FY2021.
Key figures
Market cap €2.2B Mid · P/E ratio 20.2 · P/S ratio 2.55 · EPS (TTM) €2.64 · Dividend yield 6.9% · Net margin 12.3% · Return on equity 22.0% · Return on assets (EBIT) 28.2% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 69 out of 100 (low confidence).
What moves the price
The share trades about 36% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −7% fair-value upside, at 10%, MELE screens cheaper than that median.
Fair Value models
Bear€30.84Fair Value €58.74Bull€82.49
Price €53.40 · Upside +10.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.86/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−10.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.6%
Start year 2020 (pandemic). Over 10 years: +7.7% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+17.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+10.1%
Dividend (yield on the price)6.9%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.10.1% vs 1.6%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 16%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+18.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+7.1%
Yearly sales growth analysts expect, extended to five years.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +15.9% a year for the price and +4.8% for the forecasts.
AI conclusion: Melexis benefits from specialized automotive sensors with targeted gross margin expansion toward 45 percent, yet lacks evidence of a durable competitive moat amid limited public signals.
Main risk: Soft vehicle production continues to pressure results and could delay the targeted gross margin gains in this cyclical semiconductor business.
Melexis makes specialized sensors mainly for cars and has guided for gross margins near 41 percent in the second half while aiming for 45 percent longer term. Soft vehicle production has pressured results amid wider chip sector worries. Does the next leg of margin improvement depend more on volume recovery in autos or on cost control and new applications?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductors · 370 stocks
Beats the industry median on 11/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score60 · Above median
Fair Value upside+10.0% · Top 25%
Profitability
Return on equity (12 months)22.0% · Top 25%
Return on assets12.5% · Top 25%
Net margin (12 months)12.3% · Above median
Operating margin (12 months)17.8% · Above median
Growth and dividend
Revenue growth (quarter YoY)2.6% · Below median
Dividend yield (12 months)6.9% · Top 25%
Balance sheet
Debt / equity0.62× · Highest 25%
Valuation Multiplesvs Semiconductors median · lower = cheaper
P/E (12 months)20.2× · Cheaper than median
P/B4.46× · Pricier than median
P/S (12 months)2.55× · Cheaper than median
Price / free cash flow (fiscal year)22.3× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Melexis NV Fair Value". https://www.fairvalue-calculator.com/stock/MELE
Frequently asked questions
Is Melexis NV (MELE) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of €58.74 versus a price of €53.40, about +10% upside (fairly valued).
What is the fair value of MELE?
Our model-based fair value for Melexis NV is €58.74 (as of Nov 8, 2026), built from audited fundamentals. The current price: €53.40.
What is the quality score of MELE?
Melexis NV has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Melexis NV (MELE)?
Our model-based price target is the fair value of €58.74 (as of Nov 8, 2026) from 26 valuation models. Cautious scenario €30.84, optimistic scenario €82.49. It is a calculation from audited fundamentals, not an analyst target.
What is the Melexis NV stock forecast for 2026?
Our models put fair value at €58.74, about +10% upside versus a price of €53.40 (fairly valued). Cautious scenario €30.84, optimistic scenario €82.49. The calculation is refreshed regularly with new filings.
What is the revenue of Melexis NV (MELE)?
Melexis NV reported trailing-twelve-month revenue of about €849M (latest available figure, as of Nov 8, 2026).
Does Melexis NV pay a dividend?
Melexis NV currently shows a dividend yield of 6.93% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Melexis NV (MELE) and when is the ex-dividend date?
Melexis NV pays a dividend of €3.70 per share a year, a dividend yield of 6.9%. The last ex-dividend date was Oct 13, 2026. A dividend has been paid every year since at least 2002. The payout ratio is 140% of earnings. Free cash flow covers the dividend 0.67 times. Our assessment: Pays more than it earns. The company pays out more in dividends than it earns, and free cash flow clearly does not cover the dividend either. It may need to be cut unless profits recover.
What growth is priced into Melexis NV (MELE)?
For today's price to be fair in a discounted-cash-flow model, Melexis NV would have to grow free cash flow by +18.4 % per year for five years (discount rate 11.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.6 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of MELE use?
Our models discount Melexis NV at 11.5 %: a base by market capitalisation (mid), damped by beta 1.49, country premium for Belgium. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Melexis NV that is +18.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.5 %) and the same formula as our fair value.
How much growth has Melexis NV (MELE) delivered so far?
Over the past 5 years revenue at Melexis NV grew +10.6 % a year. The price currently implies free-cash-flow growth of +18.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Melexis NV (MELE) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into Melexis NV (+18.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Melexis NV (MELE)?
The free-cash-flow yield on the price is 4.49 %: that much free cash flow Melexis NV produces per unit of market value. When it exceeds the discount rate of our models (11.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Melexis NV (MELE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Melexis NV it is €58.74 per share (as of Nov 8, 2026), against a price of €53.40. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Melexis NV stock overvalued or undervalued in 2026?
As of Nov 8, 2026, MELE trades below its calculated fair value: price €53.40, fair value €58.74, a gap of about +10% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MELE?
No. The price is what the market pays today (€53.40); the fair value is what the company's own numbers justify (€58.74). For Melexis NV the two are €5.34 per share apart. That gap is exactly why we show both numbers side by side.
How much is Melexis NV worth?
The market values Melexis NV at about €2.2B (market capitalisation, as of Nov 8, 2026). Per share that is €53.40; our models calculate a fair value of €58.74 per share.
What do the bullish and bearish scenarios say about MELE?
Our models span a range for Melexis NV: cautious scenario €30.84, base €58.74, optimistic €82.49 per share (as of Nov 8, 2026, price €53.40). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MELE?
Melexis NV trades at a price-to-earnings ratio of 20.2 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €58.74 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, FY2025 ex one-offs: 23.7. Other multiples: PEG 1.4, P/B 4.5, P/S 2.5, EV/EBITDA 12.7.
What is the PEG ratio of MELE?
The PEG ratio of Melexis NV is 1.42 (P/E divided by earnings growth, as of Nov 8, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Melexis NV (MELE)?
Balance-sheet figures for Melexis NV (as of Nov 8, 2026): return on equity 22.0%, debt of 0.62 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is MELE from its 52-week high?
Melexis NV trades at €53.40, about 36% below its 52-week high of €84.05 and 13% above the low of €47.35 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of €58.74 is for.
Which stocks are comparable to Melexis NV?
From the same area (Technology) we also value NVIDIA Corporation, Taiwan Semiconductor Manufacturing Company, Broadcom Inc, Micron Technology, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Melexis NV stock attractive at the current price?
The data as of Nov 8, 2026: price €53.40, calculated fair value €58.74 (+10%), Quality Score 60/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MELE calculated?
We run Melexis NV through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of €58.74 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Melexis NV currently trades 9% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Melexis NV (MELE)?
The closing price on Nov 6, 2026 was €53.40. Our model-based fair value is €58.74, about +10% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Melexis NV right now?
The model range is unusually wide (€30.84 to €82.49). The outcome hinges heavily on assumptions, so read the point estimate with caution. The price sits close to our fair value, market and models broadly agree here, little valuation tension.
Where does the earnings growth of Melexis NV (MELE) come from?
Earnings per share at Melexis NV grew +6.5 % a year from 2014 to 2025. Broken into its drivers: revenue per share +9.7 %, EBIT margin −1.7 %, tax rate −0.8 %, residual (interest, one-offs) −0.5 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Melexis NV
How large is the market capitalisation of Melexis NV (MELE)?
The market capitalisation of Melexis NV is €2.2B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Melexis NV (MELE)?
The price-to-sales ratio of Melexis NV is 2.55 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Melexis NV (MELE)?
Earnings per share at Melexis NV are €2.64 (price ÷ EPS = P/E 20.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Melexis NV (MELE)?
The dividend yield of Melexis NV is 6.9% (payout 140%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Melexis NV (MELE)?
The net margin of Melexis NV is 12.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Melexis NV (MELE)?
The return on equity (ROE) of Melexis NV is 22.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Melexis NV (MELE)?
On an EBIT basis the return on assets of Melexis NV is 28.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Melexis NV (MELE)?
The operating margin of Melexis NV is 17.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Melexis NV (MELE)?
Revenue at Melexis NV is growing +2.6% versus a year earlier (3y avg +0.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Melexis NV (MELE)?
Earnings per share at Melexis NV are growing −19.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Melexis NV (MELE) carry?
The net debt of Melexis NV is €287M (fiscal year 2025, ≈ 3.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Melexis NV in the live analysis
One click puts Melexis NV on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 8, 2026